Work

First-in-human phase 1 study of DS-1062a in patients (pts) with advanced solid tumors (AST).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps2605

Authors: Jacob M. Sands, Toshio Shimizu, Edward B. Garon, Jonathan Greenberg, Rebecca Suk Heist, Fumiaki Kobayashi, Yutaka Noguchi, Daisuke Okajima, Alexander I. Spira, Noboru Yamamoto, Tomonari Yamashita, Aaron Elliott Lisberg

Institutions: Dana-Farber Cancer Institute, National Cancer Center Hospital, University of California, Los Angeles, Daiichi Sankyo (United States), Massachusetts General Hospital, Daiichi-Sankyo (Japan), Virginia Cancer Specialists

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4241356432

Cites:

Cited by:

Related to: 10